Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases.

Irina Zaidman,Ehud Even-Or, Elroee Aharoni,Dina Averbuch,Yael Dinur-Schejter,Adeeb NaserEddin,Mordechai Slae,Bella Shadur,Polina Stepensky

Frontiers in pediatrics（2023）

引用 0|浏览3

暂无评分

摘要

These results demonstrate a high survival rate in pediatric patients with nonmalignant diseases despite severe GVHD. Significant mortality risk factors found in these patients were the source of donor PBSC ( = 0.016) and poor response to steroid treatment ( = 0.007).

查看译文

关键词

severe acute gvhd,pediatric patients,allogeneic hsct,diseases,single-center

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要